AstraZeneca India head goes following probe
This article was originally published in Scrip
AstraZeneca Pharma India, which has been facing a series of challenges over the recent past, has announced the resignation of its managing director Anandh Balasundaram, effective 31 August.
You may also be interested in...
Scrip traces some of the prominent changes in the corner office at front-line, family-owned Indian firms Cipla and Dr Reddy’s in the decade gone by.
Glenmark has struck a deal with private equity firm True North for its gynecology business in India and Nepal.
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.